Findings identify strategy for boosting anticancer immunity and potentially a new tool for delivering genetic payloads to ...

By deploying a "tag and sort" fix using E3 ligases, scientists successfully cleared the protein buildup and restored T-cell ...

Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...

The right approaches are demonstrating that it is possible to breach the defensively designed blood-brain barrier despite its ...

The growing complexity of the field reinforces the need for standards ensuring product quality, consistency, and patient ...

Companies are adopting diverse approaches to reducing unwanted toxicities associated with cell and gene therapy.

As more products reach the market, therapy developers partner with researchers and regulators to deliver N-of-1 treatments to patients.

This highly conserved protein is largely overlooked by researchers but is at the core of immune functions, helping regulate ...

The industry has responded in part by increasing its collaboration efforts through specialist partnerships, open innovation ...

AutoNorm™ adaptive amplification technology to lower throughput sequencing workflows. The system monitors each well in real time and stops amplification individually at a user defined endpoint, ...